Follow

Submissions from 2024

 

Is Unplanned Excision of Soft Tissue Sarcomas Associated with Worse Oncological Outcomes?-A Systematic Review and Meta-Analysis, Juan Pretell

 

Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial, Ana Sandoval-Leon

 

Management of Postoperative Discitis with Debridement and Novel Technique of Local Antibiotic Instillation: Functional Outcomes from a Resource-Limited Setting, Ahmad Ozair

 

Management of sporadic intracanalicular vestibular schwannomas: A critical review and International Stereotactic Radiosurgery Society (ISRS) practice guidelines, Rupesh Kotecha and Zhenwei Zhang

 

MASCC/ISOO Clinical Practice Statement: Management of oral complications of targeted therapy, Alessandro Villa

 

Medical and Cardiac Risk Stratification and Exercise Prescription in Persons With Cancer, Adrian Cristian and Romer Orada

 

Minimally Invasive and Cost-Effective Access to Deep-Seated Intracranial Lesions Using 19F Peel-Away Sheath Introducer and "Dynamic" Retraction: Technical Note and a Case Series, Michael McDermott, Andrea Castaldi, and Vitaly Siomin

 

MRI-Guided Adaptive Radiation Therapy, Michael Chuong

 

Multicenter prospective blinded melanoma detection study with a handheld elastic scattering spectroscopy device, Naiara Braghiroli

PDF

Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial, Alessandro Villa

 

NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed GBM, Minesh Mehta

 

Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer, Alessandro Villa

 

OUTREACH: Phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL, Yuliya Linhares

 

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer, Reshma Mahtani

 

Pain management for post-treatment survivors of complex cancers: a qualitative study of opioids and cannabis, Beatriz Currier

 

Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies, Rohan Garje and Bruno Bastos

 

Patient-specific quality assurance of dynamically-collimated proton therapy treatment plans, Alonso Gutierrez and Eduardo Pons

 

PD-1 inhibition combined with intensity-modulated radiotherapy, to better serve patients with retroperitoneal lymph node metastases from gastrointestinal cancer, Michael Chuong

 

Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436), Bruno Bastos

 

Phase I trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases, Manmeet Ahluwalia

 

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial, Rupesh Kotecha

 

Preoperative carbohydrate antigen 19.9 level predicts lymph node metastasis in resectable adenocarcinoma of the head of the pancreas: a further plea for biological resectability criteria, Horacio Asbun

 

Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial, Horacio Asbun

 

Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial, Horacio Asbun

PDF

Proton Therapy: Current Status and Controversies, Robert Press and Minesh Mehta